Trial Profile
Evaluating the Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity Using a Biomarker Cocktail in Healthy Human Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Tipranavir (Primary) ; Caffeine; Dextromethorphan; Digoxin; Digoxin; Midazolam; Midazolam; Omeprazole; Ritonavir; Vitamin K; Warfarin
- Indications HIV-1 infections
- Focus Biomarker; Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 22 Sep 2014 New trial record